Review
Acute Fatty Liver of Pregnancy
Abstract
Acute fatty liver of pregnancy is a rare but serious and potentially fatal complication of pregnancy. It typically presents in the third trimester with microvesicular fatty infiltration of the liver and can lead to multiorgan failure and death. Differentiation from hemolysis-elevated liver enzymes-low platelets syndrome can guide management. A high index of suspicion is necessary in the appropriate clinical setting to identify clinical manifestations and complications and manage them appropriately. In severe cases, prompt delivery can be lifesaving for the mother and fetus. Liver transplantation remains controversial and must be considered individually. Defects in fatty acid oxidation secondary to various enzymatic deficiencies have been associated with acute fatty liver of pregnancy. Women or couples with known defects in fatty acid oxidation and women with a history of previous liver disease during pregnancy or sudden death of a child within the first 2 years of life should be assessed for a defect in fatty acid oxidation and monitored carefully. Our review summarizes the current knowledge in pathophysiology, diagnostic approach and management of this disorder.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Stander H, Cadden B. Acute yellow atrophy of the liver in pregnancy. Am J Obstet Gynecol. 1934; 28: 61–69.
2. Sheehan HL. The pathology of acute yellow atrophy and delayed chloroform poisoning. J Obstet Gynaecol Br Emp. 1940; 47: 49–62.
3. Knox TA, Olans LB. Liver disease in pregnancy. N Engl J Med. 1996; 335: 569–576.
4. Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol. 1999; 181: 389–395.
5. Knight M, Nelson-Piercy C, Kurinczuk J, et al. A prospective national study of acute fatty liver of pregnancy in the UK. Gut. 2008; 57: 951–956.
6. Buytaert IM, Elewaut GP, Van Kets HE. Early occurrence of acute fatty liver in pregnancy. Am J Gastroenterol. 1996; 91: 603–604.
7. Mjahed K, Charra B, Hamoudi D, et al. Acute fatty liver of pregnancy. Arch Gynecol Obstet. 2006; 274: 349–353.
8. Bahloul M, Dammak H, Khlaf-Bouaziz N, et al. Acute fatty liver of pregnancy. About 22 cases. Gynecol Obstet Fertil. 2006; 34: 597–606.
9. Dekker R, Schutte JM, Stekelenburg J, et al. Maternal mortality and severe maternal morbidity from acute fatty liver of pregnancy in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2011; 157: 27–31.
10. Reyes H, Sandoval L, Wainstein A, et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. Gut. 1994; 35: 101–106.
11. Usta IM, Barton JR, Gonzalez A, et al. Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gyynecol. 1994; 171: 1342–1347.
12. Mabie WC. Obstetric management of gastroenterologic complications of pregnancy. Gastroenterol Clin North Am. 1992; 21: 923–935.
13. Schoeman MN, Batey RG, Wilcken B. Recurrent acute fatty liver of pregnancy associated with a fatty acid oxidation defect in the offspring. Gastroenterology. 1991; 100: 544–548.
14. Wilcken B, Leung KC, Hammond J, et al. Pregnancy and fetal long chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet. 1993; 341: 407–408.
15. Lee N, Brady C. Liver disease in pregnancy. World J Gastroenterol. 2009; 15: 897–906.
16. Jackson S, Kler RS, Bartlett K, et al. Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest. 1992; 90: 1219–1225.
17. Wanders RJ, IJlst L, van Gennip AH, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid beta-oxidation. J Inherit Metab Dis. 1990; 13: 311–314.
18. Innes AM, Seargeant LE, Balachandra K, et al. Hepatic carnitine palmitoylotransferase I deficiency presenting as maternal illness in pregnancy. Pediatrc Res. 2000; 41: 43–45.
19. Matern D, Hart P, Murtha AP, et al. Acute fatty liver of pregnancy associated with short-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr. 2001; 138: 585–588.
20. Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999; 340: 1723–1731.
21. Natarajan SK, Thangaraj KR, Eapen CA, et al. Liver injury in acute fatty liver of pregnancy: possible link to placental mitochondrial dysfunction and oxidative stress. Hepatology. 2010; 51: 191–200.
22. Rakheja D, Bennett MJ, Foster BM, et al. Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age. Placenta. 2002; 23: 447–450.
23. Shekhawat P, Bennett MJ, Sadovsky Y, et al. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab. 2003; 284: E1098–E1105.
24. Natarajan SK, Eapen CE, Pullimood AB, et al. Oxidative stress in experimental liver microvesicular steatosis: role of mitochondria and peroxisomes. J Gastroenterol Hepatol. 2006; 21: 1240–1249.
25. Wang Y, Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta. 1998; 19: 581–586.
26. Dani R, Mendes GS, Medeiros Jde L, et al. Study of the liver changes occurring in preeclampsia and their possible pathogenetic connection with acute fatty liver of pregnancy. Am J Gastroenterol. 1996; 91: 292–294.
27. Mannaerts GP, Debeer LJ, Thomas J, et al. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats. J Biol Chem. 1979; 254: 4585–4595.
28. Hashimoto T, Fujita T, Usuda N, et al. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisomes proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem. 1999; 274: 19228–19236.
29. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996; 271: C1424–C1437.
30. Cocco T, Di Paola M, Papa S, et al. Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. Free Radic Biol Med. 1999; 27: 51–59.
31. Fesenmeier MF, Coppage KH, Lambers DS, et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol. 2005; 192: 1416–1419.
32. Riely CA. Acute fatty liver of pregnancy. Semin Liver Dis. 1987; 7: 47–54.
33. Usta IM, Barton JR, Amon EA, et al. Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol. 1994; 171: 1342–1347.
34. Rolfes DB, Ishak KG. Acute fatty liver of pregnancy; a clinicopathologic study of 35 cases. Hepatology. 1985; 5: 1149–1158.
35. Kaplan MM. Acute fatty liver of pregnancy. N Engl J Med. 1985; 313: 367–370.
36. Castro MA, Goodwin TM, Shaw KJ. Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol. 1996; 174: 211–216.
37. Pereira SP, O’Donohue J, Wendon J, et al. Maternal and perinatal outcome in severe pregnancy-related liver disease. Hepatology. 1997; 26: 1258–1262.
38. Moldenhauer JS, O’Brien JM, Barton JR, et al. Acute fatty liver of pregnancy associated with pancreatitis: a life threatening complication. Am J Obstet Gynecol. 2004; 190: 502–505.
39. Kirkland EB, Sachdev R, Kim J, et al. Early pancreatic panniculitis associated with HELLP syndrome and acute fatty liver of pregnancy. J Cutan Pathol. 2011; 38: 814–817.
40. Kennedy S, Hall PM, Seymour AE, et al. Transient diabetes insipidus and acute fatty liver of pregnancy. Br J Obstet Gynaecol. 1994; 101: 387–391.
41. Hay JE. Liver disease in pregnancy. Hepatology. 2008; 47: 1067–1076.
42. Eguchi S, Yanaga K, Fujita F, et al. Living-related right lobe liver transplantation for a patient with fulminant hepatic failure during the second trimester of pregnancy: report of a case. Transplantation. 2002; 73: 1970–1971.
43. Koenen SV, Huisjes AJ, Dings J, et al. Is there a diurnal pattern in the clinical symptoms of HELLP syndrome? J Matern Fetal Neonatal Med. 2006; 19: 93–99.
44. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009; 9: 8
45. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): how much to do about nothing? Am J Obstet Gynecol. 1990; 162: 311–316.
46. Sibai BM. Imitators of severe pre-eclampsia/eclampsia. Clin Perinatol. 2004; 31: 835–852.
47. Steingrub JS. Pregnancy-associated severe liver dysfunction. Crit Care Clin. 2004; 20: 763–776.
48. Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy. Lancet. 2010; 375: 594–605.
49. Saygan-Karamursel B, Kizilkilic-Parlakgumus A, Daren O, et al. Acute fatty liver of pregnancy after aspirin intake. J Matern Fetal Neonatal Med. 2004; 16: 65–66.
50. Vigil de Gracia P, Montufar-Rueda C. Acute fatty liver of pregnancy: diagnosis, treatment, and outcome based on 35 consecutive cases. J Matern Fetal Neonatal Med. 2011; 24: 1143–1146.
51. Douvres PA, Rosenthal WS, Metzger P, et al. Acute fatty liver of pregnancy with hepatic coma and Mallory Weiss syndrome: report of a case. Am J Dig Dis. 1965; 10: 306–313.
52. Schorr-Losnich B, Lebovics E, Dworkin B, et al. Liver diseases unique to pregnancy. Am J Gastroenterol. 1991; 86: 659–670.
53. Vanlak D, Moreau R, Roche-Sicot J, et al. Intrahepatic cholestasis of pregnancy and acute fatty liver of pregnancy. An unusual but favorable association. Gastroenterology. 1991; 100: 1123–1125.
54. Wei Q, Zhang L, Liu X. Clinical diagnosis and treatment of acute fatty liver of pregnancy: a literature review and 11 new cases. JjObstet Gynaecol Res. 2010; 36: 751–756.
55. Gregory TL, Hughes S, Coleman MA, et al. Acute fatty liver of pregnancy; three cases and discussion of analgesia and anesthesia. Int J Obstet Anesth. 2007; 16: 175–179.
56. Leonard JV, Dezateux C. Newborn screening for medium chain acyl CoA dehydrogenase deficiency. Arch Dis Child. 2009; 94: 235–238.
57. Amon E, Allen SR, Petri RH, et al. Acute fatty liver of pregnancy associated with preeclampsia: management of hepatic failure with postpartum liver transplantation. Am J Perinatol. 1991; 8: 278–279.
58. Ockner SA, Brunt EM, Cohn SM, et al. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology. 1990; 11: 59–64.
59. Remiszewski P, Pawlak J, Skwarek A, et al. Orthotopic liver transplantation for acute liver failure resulting from “acute fatty liver of pregnancy.”. Ann Transpl. 2003; 8: 8–11.
60. Shames BD, Fernandez LA, Sollinger HW, et al. Liver transplantation for HELLP syndrome. Liver Transpl. 2005; 11: 224–228.
61. Westbrook RH, Yeoman AD, Joshi D, et al. Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am J Transpl. 2010; 10: 2520–2526.
62. Franco J, Newcomer J, Adams M, et al. Auxiliary liver transplant in acute fatty liver of pregnancy. Obstet Gynecol. 2000; 95: 1042
